Morning Market Losers
November 11, 2013 at 10:16 AM EST
Zalicus (NASDAQ: ZLCS ) plummeted 71.61% to $1.33 after the company reported results from Phase 2 clinical trials of Z160 in chronic neuropathic pain. RadNet (NASDAQ: RDNT ) dropped 14.05% to $2.0199 after the company reported Q3 results. Ballantyne Strong (NYSE: BTN ) dropped 12.55% to $4.18 on
